128 related articles for article (PubMed ID: 21868542)
21. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma.
Gandini S; Boniol M; Haukka J; Byrnes G; Cox B; Sneyd MJ; Mullie P; Autier P
Int J Cancer; 2011 Mar; 128(6):1414-24. PubMed ID: 20473927
[TBL] [Abstract][Full Text] [Related]
22. Plasma 25-hydroxyvitamin D and premenopausal breast cancer risk in a German case-control study.
Abbas S; Chang-Claude J; Linseisen J
Int J Cancer; 2009 Jan; 124(1):250-5. PubMed ID: 18839430
[TBL] [Abstract][Full Text] [Related]
23. Circulating Vitamin D and Overall Survival in Breast Cancer Patients: A Dose-Response Meta-Analysis of Cohort Studies.
Hu K; Callen DF; Li J; Zheng H
Integr Cancer Ther; 2018 Jun; 17(2):217-225. PubMed ID: 28589744
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of vitamin D, calcium and the prevention of breast cancer.
Chen P; Hu P; Xie D; Qin Y; Wang F; Wang H
Breast Cancer Res Treat; 2010 Jun; 121(2):469-77. PubMed ID: 19851861
[TBL] [Abstract][Full Text] [Related]
25. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers.
Grant WB
J Photochem Photobiol B; 2010 Nov; 101(2):130-6. PubMed ID: 20570169
[TBL] [Abstract][Full Text] [Related]
26. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
[TBL] [Abstract][Full Text] [Related]
27. Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin d.
Brisson J; Bérubé S; Diorio C; Sinotte M; Pollak M; Mâsse B
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):929-33. PubMed ID: 17507618
[TBL] [Abstract][Full Text] [Related]
28. Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis.
Gorham ED; Garland CF; Garland FC; Grant WB; Mohr SB; Lipkin M; Newmark HL; Giovannucci E; Wei M; Holick MF
Am J Prev Med; 2007 Mar; 32(3):210-6. PubMed ID: 17296473
[TBL] [Abstract][Full Text] [Related]
29. The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.
Neuhouser ML; Manson JE; Millen A; Pettinger M; Margolis K; Jacobs ET; Shikany JM; Vitolins M; Adams-Campbell L; Liu S; LeBlanc E; Johnson KC; Wactawski-Wende J
Am J Epidemiol; 2012 Apr; 175(7):673-84. PubMed ID: 22362582
[TBL] [Abstract][Full Text] [Related]
30. Review: the impacts of circulating 25-hydroxyvitamin D levels on cancer patient outcomes: a systematic review and meta-analysis.
Li M; Chen P; Li J; Chu R; Xie D; Wang H
J Clin Endocrinol Metab; 2014 Jul; 99(7):2327-36. PubMed ID: 24780061
[TBL] [Abstract][Full Text] [Related]
31. [Vitamin D and breast cancer: is there a link?].
Stoll F; Akladios CY; Mathelin C
Gynecol Obstet Fertil; 2013 Apr; 41(4):242-50. PubMed ID: 23562418
[TBL] [Abstract][Full Text] [Related]
32. Association of 25-hydroxyvitamin D level with survival outcomes in female breast cancer patients: A meta-analysis.
Li C; Li H; Zhong H; Li X
J Steroid Biochem Mol Biol; 2021 Sep; 212():105947. PubMed ID: 34214604
[TBL] [Abstract][Full Text] [Related]
33. The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture.
Feng Y; Cheng G; Wang H; Chen B
Osteoporos Int; 2017 May; 28(5):1641-1652. PubMed ID: 28220196
[TBL] [Abstract][Full Text] [Related]
34. Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study.
Rejnmark L; Tietze A; Vestergaard P; Buhl L; Lehbrink M; Heickendorff L; Mosekilde L
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2655-60. PubMed ID: 19789365
[TBL] [Abstract][Full Text] [Related]
35. Serum 25-hydroxyvitamin D and breast cancer risk by pathological subtype (MCC-Spain).
Lope V; Castelló A; Mena-Bravo A; Amiano P; Aragonés N; Fernández-Villa T; Guevara M; Dierssen-Sotos T; Fernandez-Tardón G; Castaño-Vinyals G; Marcos-Gragera R; Moreno V; Salas-Trejo D; Diaz-Santos M; Oribe M; Romieu I; Kogevinas M; Priego-Capote F; Pérez-Gómez B; Pollán M
J Steroid Biochem Mol Biol; 2018 Sep; 182():4-13. PubMed ID: 29679754
[TBL] [Abstract][Full Text] [Related]
36. Serum 25-hydroxyvitamin D levels in early and advanced breast cancer.
Palmieri C; MacGregor T; Girgis S; Vigushin D
J Clin Pathol; 2006 Dec; 59(12):1334-6. PubMed ID: 17046848
[TBL] [Abstract][Full Text] [Related]
37. Association of serum level of 25 hydroxy-vitamin D with prognostic factors for breast cancer.
Kermani IA; Kojidi HT; Gharamaleki JV; Sanaat Z; Ziaei JE; Esfahani A; Seifi S; Ghojazadeh M; Dolatkhah R; Kermani AA; Rad EG
Asian Pac J Cancer Prev; 2011; 12(6):1381-4. PubMed ID: 22126468
[TBL] [Abstract][Full Text] [Related]
38. High serum 25-hydroxyvitamin D is associated with a low incidence of stress fractures.
Burgi AA; Gorham ED; Garland CF; Mohr SB; Garland FC; Zeng K; Thompson K; Lappe JM
J Bone Miner Res; 2011 Oct; 26(10):2371-7. PubMed ID: 21698667
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D and prevention of colorectal adenoma: a meta-analysis.
Wei MY; Garland CF; Gorham ED; Mohr SB; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):2958-69. PubMed ID: 18990737
[TBL] [Abstract][Full Text] [Related]
40. The relationship between breast cancer treatment, tumour type and vitamin D level in pre- and postmenopausal women.
Streb J; Glanowska I; Streb A; Szpor J; Kryka K; Potocki P; Wójcik M; Jach R
Neuro Endocrinol Lett; 2017 Dec; 38(6):437-440. PubMed ID: 29298285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
